BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28418523)

  • 1. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
    Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
    JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy.
    Kühl JS; Kupper J; Baqué H; Ebell W; Gärtner J; Korenke C; Spors B; Steffen IG; Strauss G; Voigt S; Weschke B; Weddige A; Köhler W; Steinfeld R
    JAMA Netw Open; 2018 Jul; 1(3):e180769. PubMed ID: 30646031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential outcomes for frontal versus posterior demyelination in childhood cerebral adrenoleukodystrophy.
    Gupta AO; Nascene DR; Shanley R; Kenney-Jung DL; Eisengart JB; Lund TC; Orchard PJ; Pierpont EI
    J Inherit Metab Dis; 2021 Nov; 44(6):1434-1440. PubMed ID: 34499753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.
    Raymond GV; Aubourg P; Paker A; Escolar M; Fischer A; Blanche S; Baruchel A; Dalle JH; Michel G; Prasad V; Miller W; Paadre S; Balser J; Kurtzberg J; Nascene DR; Orchard PJ; Lund T
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):538-548. PubMed ID: 30292747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy.
    Pierpont EI; Nascene DR; Shanley R; Kenney-Jung DL; Ziegler RS; Miller WP; Gupta AO; Lund TC; Orchard PJ; Eisengart JB
    Neurology; 2020 Aug; 95(5):e591-e600. PubMed ID: 32616675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life among boys with adrenoleukodystrophy following hematopoietic stem cell transplant.
    Beckmann NB; Miller WP; Dietrich MS; Orchard PJ
    Child Neuropsychol; 2018 Oct; 24(7):986-998. PubMed ID: 28934891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
    Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
    JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation in patients with childhood cerebral adrenoleukodystrophy: A single-center experience "Better prognosis in earlier stage".
    Yalcin K; Çelen SS; Daloglu H; Demir MK; Öztürkmen S; Pasayev D; Zhumatayev S; Uygun V; Hazar V; Karasu G; Yesilipek A
    Pediatr Transplant; 2021 Jun; 25(4):e14015. PubMed ID: 33780114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy.
    Pierpont EI; McCoy E; King KE; Ziegler RS; Shanley R; Nascene D; Raymond GV; Phelan R; Lund TC; Orchard PJ; Miller WP
    Ann Clin Transl Neurol; 2018 Mar; 5(3):252-261. PubMed ID: 29560371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy.
    Kühl JS; Suarez F; Gillett GT; Hemmati PG; Snowden JA; Stadler M; Vuong GL; Aubourg P; Köhler W; Arnold R
    Brain; 2017 Apr; 140(4):953-966. PubMed ID: 28375456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neuropsychological signs of childhood adrenoleukodystrophy (ALD).
    Kaga M; Furushima W; Inagaki M; Nakamura M
    Brain Dev; 2009 Aug; 31(7):558-61. PubMed ID: 19497692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
    Thibert KA; Raymond GV; Nascene DR; Miller WP; Tolar J; Orchard PJ; Lund TC
    PLoS One; 2012; 7(11):e50430. PubMed ID: 23185624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation.
    McKinney AM; Benson JC; Nascene DR; Eisengart J; Salmela MB; Loes DJ; Zhang L; Patel K; Raymond GV; Miller WP
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1713-20. PubMed ID: 27079370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy.
    Baumann M; Korenke GC; Weddige-Diedrichs A; Wilichowski E; Hunneman DH; Wilken B; Brockmann K; Klingebiel T; Niethammer D; Kühl J; Ebell W; Hanefeld F
    Eur J Pediatr; 2003 Jan; 162(1):6-14. PubMed ID: 12486501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.
    Miller WP; Rothman SM; Nascene D; Kivisto T; DeFor TE; Ziegler RS; Eisengart J; Leiser K; Raymond G; Lund TC; Tolar J; Orchard PJ
    Blood; 2011 Aug; 118(7):1971-8. PubMed ID: 21586746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for vision loss after hematopoietic cell transplant for X-linked adrenoleukodystrophy.
    Gess A; Christiansen SP; Pond D; Peters C
    J AAPOS; 2008 Jun; 12(3):273-6. PubMed ID: 18359652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.
    Turk BR; Theisen BE; Nemeth CL; Marx JS; Shi X; Rosen M; Jones RO; Moser AB; Watkins PA; Raymond GV; Tiffany C; Fatemi A
    JAMA Neurol; 2017 May; 74(5):519-524. PubMed ID: 28288261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy.
    Gupta A; Orchard PJ; Miller WP; Nascene DR; Raymond GV; Loes DJ; McKenna DH; Lund TC
    Stem Cells Transl Med; 2020 May; 9(5):554-558. PubMed ID: 32020747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
    Eichler F; Duncan C; Musolino PL; Orchard PJ; De Oliveira S; Thrasher AJ; Armant M; Dansereau C; Lund TC; Miller WP; Raymond GV; Sankar R; Shah AJ; Sevin C; Gaspar HB; Gissen P; Amartino H; Bratkovic D; Smith NJC; Paker AM; Shamir E; O'Meara T; Davidson D; Aubourg P; Williams DA
    N Engl J Med; 2017 Oct; 377(17):1630-1638. PubMed ID: 28976817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to Transplant in X-Linked Adrenoleukodystrophy.
    Bonkowsky JL; Wilkes J
    J Child Neurol; 2022 Apr; 37(5):397-400. PubMed ID: 35238239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.